Skip to content
Search

Latest Stories

RPS, RCGP to develop toolkit to improve consistency of repeat prescribing

NHS England has commissioned the Royal Pharmaceutical Society (RPS) in collaboration with the Royal College of General Practitioners (RCGP) to develop tools and guidance that will help primary care to improve repeat prescribing. 

A toolkit will be produced to improve the consistency of repeat prescribing processes and provide training resources so the healthcare system aligns more closely to improve repeat prescribing for better patient care.


The guidance follows NHS England’s plan to reduce overprescribing Good for you, good for us, good for everybody which made 20 cross system recommendations to address overprescribing in England and ensure patients get the right treatment for their needs.

Over the next 18 months, RPS and RCGP will bring together a working group to- scope current best practice to help shape the toolkit; consult with healthcare professionals on a draft version of the toolkit; create an implementation plan for GP practices and pharmacies; and capture the impact of the toolkit on patient care and its implementation by practices and pharmacies.

The working group will be co-chaired by RPS Fellow Clare Howard, Clinical Lead for the Academic Health Science Network Polypharmacy Programme and Dr Michael Mulholland, Honorary Secretary of the RCGP.

Clare Howard, clinical adviser and lead for the development and implementation of the toolkit said: "I’m delighted to be working on this toolkit with the RPS and RCGP. We prescribe and dispense well over 1 billion prescription items in England in primary care and over 75% of those items are repeat prescriptions.

“The vast majority of medicines are prescribed and dispensed safely, but we know from the evidence that there are risks in our systems and as these systems get busier, with more and more people on multiple medicines, we need to ensure that our processes are both safe for our patients and efficient for our primary care work force. 

“We will develop a toolkit to help GP practices and PCNs to understand where the risks in their local arrangements might be and how to address them to ensure systems are run safely and also reduce unnecessary burdens on our valuable clinical workforce.”

Dr Tony Avery, GP and Professor of Primary Health Care University of Nottingham and National Clinical Director for Prescribing, NHS England, said: “Having medicines on repeat prescription makes life easier for patients, general practices and community pharmacies, but problems and waste can occur if the repeat prescription process is not designed well, or if patients’ medicines are not reviewed on a regular basis.

“The guidance and training resources that will be developed by the RPS and RCGP will ensure that repeat prescribing systems work well for patients and NHS primary care teams, reduce inefficiency and waste and, most importantly, keep patients safe.”

The final toolkit will be published in May 2024.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less